Company to invest in further research to strengthen clinical evidence ahead of medium-term U.S. launch with no further FDA approvals needed PERTH, Australia, Nov. 20, 2025 /PRNewswire/ -- Orthocell ...

Learn about prostate cancer symptoms, diagnosis, staging and the latest treatments including robotic surgery, SBRT, radioligand therapy and targeted drugs.

PERTH, Australia, Nov. 20, 2025 /PRNewswire/ -- Orthocell Limited (ASX: OCC) is pleased to announce adoption of Remplir™ by Australian urologists is accelerating with the product increasingly being ...

3D augmented reality-assisted imaging during RARP enabled precise identification and removal of tumor lesions at the level of preserved neurovascular bundles, which may reduce positive surgical ...

Electroacupuncture targeting the sacral nerve may promote early return of urinary continence after nerve-sparing radical prostatectomy. Electroacupuncture to the Ciliao, Zhongliao, and Xialiao ...

LAS VEGAS -- Focused ultrasound ablation for prostate cancer proved at least equivalent to radical prostatectomy for failure-free survival, according to a randomized trial reported here. After 3 years ...

To summarize the evolution and future of technologies and techniques that assist in providing good functional outcomes during nerve-sparing robot-assisted radical prostatectomy. Recent data underscore ...

Pilot study evaluates safety and tolerability of implantable neuromodulation therapy for erectile dysfunction following radical prostatectomy LAUSANNE, Switzerland, Oct. 01, 2025 (GLOBE NEWSWIRE) -- ...